PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
16-Aug-2021 Enveda Biosciences Boosts its Translational Capabilities with Two Key Hires Businesswire
16-Aug-2021 Technicolor Precision BioDevices to Manufacture Scope Fluidics’ BacterOMIC System Cartridges Businesswire
16-Aug-2021 PharmaCyte Biotech Releases Statement on Nasdaq Uplisting and Current Business Focus Businesswire
16-Aug-2021 ClinEdge & Skylight Health Expand Partnership Newswire
16-Aug-2021 Calidi Biotherapeutics Announces Exclusive License Agreement with City of Hope and the University of Chicago for Novel Oncolytic Virotherapy Technology Businesswire
16-Aug-2021 Moderna Announces First Patient Dosed in Phase 1/2 Study of mRNA-3705 for Methylmalonic Acidemia Businesswire
16-Aug-2021 Exelixis and Invenra Expand Collaboration to Discover and Develop Novel Biologics in Oncology Businesswire
16-Aug-2021 Can Seaweed Reduce the Scourge of Plastic Waste? Packaging Leader DS Smith Looking to Use Seaweed as Alternative Fiber Source Businesswire
16-Aug-2021 ReCode Therapeutics Appoints Angèle Maki, Ph.D., as Senior Vice President of Business Development Businesswire
16-Aug-2021 LARVOL CEO Launches One Year in the Metaverse Businesswire
16-Aug-2021 Two-Thirds of Americans Have Had a Negative Health Care Experience, According to Accenture Research Businesswire
16-Aug-2021 Axcella Announces Publication in The American Journal of Gastroenterology of Positive Results from AXA1125-003 in Subjects With Presumed NASH Businesswire
16-Aug-2021 UnityPoint Health Selects Premier Inc. for Strategic Supply Chain Partnership Businesswire
16-Aug-2021 Virios Therapeutics CEO Highlights Novel Therapeutic Approach for Treating Fibromyalgia and Irritable Bowel Syndrome in Stock News Now Video Interview Businesswire
16-Aug-2021 Enanta Pharmaceuticals Doses First Subject in a Phase 1 Clinical Study of EDP-721, Its Oral Hepatitis B Virus RNA Destabilizer Businesswire
16-Aug-2021 BeiGene to Host Investor Conference Call and Webcast to Discuss the Company’s Early Development Pipeline and Research on August 25, 2021 Businesswire
16-Aug-2021 Worldwide Antimicrobial Additives Industry to 2030 - Increasing Health Awareness Among Consumers is Driving Growth - ResearchAndMarkets.com Businesswire
13-Aug-2021 FDA Approves Merck’s Hypoxia-Inducible Factor-2 Alpha (HIF-2α) Inhibitor WELIREG™ (belzutifan) for the Treatment of Patients With Certain Types of Von Hippel-Lindau (VHL) Disease-Associated Tumors Businesswire
13-Aug-2021 Cybin Inc. Announces 2021 First Quarter Financial Results and Business Highlights Businesswire
13-Aug-2021 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of LifeStance Health Group, Inc. (LFST) on Behalf of Investors Businesswire